Frizzled Receptors as Potential Therapeutic Targets in Human Cancers

被引:74
|
作者
Zeng, Chui-Mian [1 ,2 ]
Chen, Zhe [3 ]
Fu, Li [1 ,2 ]
机构
[1] Shenzhen Univ, Sch Med, Dept Pharmacol, Guangdong Key Lab Genome Stabil & Dis Prevent, Shenzhen 518060, Peoples R China
[2] Shenzhen Univ, Sch Med, Carson Int Canc Res Ctr, Shenzhen 518060, Peoples R China
[3] Zhejiang Chinese Med Univ, Zhejiang Hosp Tradit Chinese Med, Zhejiang Key Lab Gastrointestinal Pathophysiol, Hangzhou 310006, Zhejiang, Peoples R China
基金
国家重点研发计划; 中国国家自然科学基金;
关键词
frizzled receptors; WNT signaling pathway; cancer therapy; antibody; small molecule inhibitor; WNT/BETA-CATENIN PATHWAY; CELL LUNG-CANCER; EPITHELIAL-MESENCHYMAL TRANSITION; NEGATIVE BREAST-CANCER; ACUTE MYELOID-LEUKEMIA; HUMAN SYNOVIAL SARCOMA; STEM-LIKE CELLS; DOWN-REGULATION; BETA-CATENIN; SIGNALING PATHWAY;
D O I
10.3390/ijms19051543
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Frizzled receptors (FZDs) are a family of seven-span transmembrane receptors with hallmarks of G protein-coupled receptors (GPCRs) that serve as receptors for secreted Wingless-type (WNT) ligands in the WNT signaling pathway. Functionally, FZDs play crucial roles in regulating cell polarity, embryonic development, cell proliferation, formation of neural synapses, and many other processes in developing and adult organisms. In this review, we will introduce the basic structural features and review the biological function and mechanism of FZDs in the progression of human cancers, followed by an analysis of clinical relevance and therapeutic potential of FZDs. We will focus on the development of antibody-based and small molecule inhibitor-based therapeutic strategies by targeting FZDs for human cancers.
引用
收藏
页数:18
相关论文
共 50 条
  • [1] Frizzled receptors (FZDs) in Wnt signaling: potential therapeutic targets for human cancers
    Liu, Hui-yu
    Sun, Xiao-jiao
    Xiu, Si-yu
    Zhang, Xiang-yu
    Wang, Zhi-qi
    Gu, Yan-lun
    Yi, Chu-xiao
    Liu, Jun-yan
    Dai, Yu-song
    Yuan, Xia
    Liao, Hua-peng
    Liu, Zhen-ming
    Pang, Xiao-cong
    Li, Tian-cheng
    ACTA PHARMACOLOGICA SINICA, 2024, 45 (08) : 1556 - 1570
  • [2] Subunits of human condensins are potential therapeutic targets for cancers
    Wang, Hong-Zhen
    Yang, Si-Han
    Li, Gui-Ying
    Cao, Xudong
    CELL DIVISION, 2018, 13
  • [3] Subunits of human condensins are potential therapeutic targets for cancers
    Hong-Zhen Wang
    Si-Han Yang
    Gui-Ying Li
    Xudong Cao
    Cell Division, 13
  • [4] Frizzled receptors (FZD) play multiple cellular roles in development, in diseases, and as potential therapeutic targets
    Alrefaei, Abdulmajeed F.
    JOURNAL OF KING SAUD UNIVERSITY SCIENCE, 2021, 33 (08)
  • [5] MicroRNAs as therapeutic targets in human cancers
    Shah, Maitri Y.
    Calin, George A.
    WILEY INTERDISCIPLINARY REVIEWS-RNA, 2014, 5 (04) : 537 - 548
  • [6] GABAB Receptors as Potential Therapeutic Targets
    Vacher, Claire-Marie
    Bettler, Bernhard
    CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2003, 2 (04) : 248 - 259
  • [7] Adenosine receptors as potential therapeutic targets
    Kaiser, SM
    Quinn, RJ
    DRUG DISCOVERY TODAY, 1999, 4 (12) : 542 - 551
  • [8] Leukotriene receptors as potential therapeutic targets
    Yokomizo, Takehiko
    Nakamura, Motonao
    Shimizu, Takao
    JOURNAL OF CLINICAL INVESTIGATION, 2018, 128 (07): : 2691 - 2701
  • [9] Adenosine Receptors as Potential Therapeutic Analgesic Targets
    Haddad, Mansour
    Cherchi, Federica
    Alsalem, Mohammad
    Al-saraireh, Yousef M.
    Madae'en, Saba
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (17)
  • [10] Aryl hydrocarbon receptors as potential therapeutic targets
    Andreeva-Gateva, Pavlina
    Bakalov, Dimitar
    Sabit, Zafer
    Tafradjiiska-Hadjiolova, Radka
    PHARMACIA, 2020, 67 (04) : 311 - 315